Integrative Tissue Analysis of Men with Prostate Cancer
Demographics (1)
- SEX - Biological sex (phv00493280.v2.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject for prostrate cancer (phv00407225.v3.p1)
- PSA - Baseline PSA at time of diagnosis (phv00407227.v3.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00407229.v3.p1)
Other (16)
- 5_YEAR_DISEASE_STATUS - Recurrence status at 5 years post-surgery (phv00493281.v2.p1)
- ANALYTE_TYPE - Analyte Type (phv00407232.v3.p1)
- BODY_SITE - Body site where sample was collected (phv00407231.v3.p1)
- CONSENT - Consent group as determined by DAC (phv00407219.v3.p1)
- GEO_ACCESSION - GEO accession ID (phv00407223.v3.p1)
- GLEASON_SCORE - Gleason score at diagnosis (phv00407228.v3.p1)
- IS_TUMOR - Tumor status (phv00407233.v3.p1)
- REGION - Histopathologic features or identifier in the region of interest (phv00407234.v3.p1)
- SAMPLE_ID - Sample ID (phv00407230.v3.p1)
- SAMPLE_ID - Sample ID (phv00407221.v3.p1)
- SAMPLE_ID - Sample ID (phv00407222.v3.p1)
- SAMPLE_TIMING - Disease status when sample was acquired (phv00493283.v2.p1)
- STAGE - Pathologic T stage (phv00493282.v2.p1)
- SUBJECT_ID - Subject ID (phv00407224.v3.p1)
- SUBJECT_ID - Subject ID (phv00407218.v3.p1)
- SUBJECT_ID - Subject ID (phv00407220.v3.p1)